Biomarin Pharmaceuticals (BMRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | BMRN | GMAB | SRPT | ||
Company | Biomarin Pharmaceuticals | Genmab A/S ADR | Sarepta Therapeutics | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 82.08 | 24.70 | 156.46 | ||
High | 82.43 | 24.92 | 156.70 | ||
Low | 81.55 | 24.53 | 153.65 | ||
Last | 82.22 | 24.90 | 154.20 | ||
Change | +0.09 | +0.05 | -2.55 | ||
% Change | +0.11% | +0.20% | -1.63% | ||
Volume | 1,064,200 | 750,100 | 1,327,100 | ||
20-Day Average Volume | 4,089,580 | 566,440 | 2,360,390 | ||
Previous Close | 82.13 | 24.85 | 156.75 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | Yes | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 83.13 | 26.47 | 135.82 | ||
20-Day Raw Stochastic | 61.85% | 8.35% | 66.88% | ||
20-Day Relative Strength | 49.44% | 31.31% | 63.02% | ||
Weighted Alpha | -6.04 | -35.10 | +47.60 | ||
Today's Opinion | 56% Sell | 100% Sell | 100% Buy | ||
Previous Opinion | 56% Sell | 100% Sell | 100% Buy | ||
Last Month's Opinion | 100% Sell | 88% Sell | 88% Buy | ||
Performance | |||||
5-Days | |||||
%Chg | -3.24% since 06/25/24 | -3.41% since 06/25/24 | -2.44% since 06/25/24 | ||
Low | 81.55 on 07/02/24 | 24.53 on 07/02/24 | 151.26 on 06/26/24 | ||
High | 85.50 on 06/26/24 | 25.77 on 06/27/24 | 162.95 on 07/01/24 | ||
1-Month | |||||
%Chg | +9.52% since 05/31/24 | -11.70% since 05/31/24 | +18.74% since 05/31/24 | ||
Low | 75.40 on 06/03/24 | 24.53 on 07/02/24 | 115.74 on 06/20/24 | ||
High | 86.13 on 06/18/24 | 28.96 on 06/05/24 | 173.25 on 06/21/24 | ||
3-Month | |||||
%Chg | -5.28% since 04/02/24 | -16.89% since 04/02/24 | +21.42% since 04/02/24 | ||
Low | 73.68 on 05/30/24 | 24.53 on 07/02/24 | 109.91 on 05/28/24 | ||
High | 93.36 on 04/15/24 | 30.50 on 04/04/24 | 173.25 on 06/21/24 | ||
6-Month | |||||
%Chg | -16.14% since 01/02/24 | -22.45% since 01/02/24 | +60.27% since 01/02/24 | ||
Low | 73.68 on 05/30/24 | 24.53 on 07/02/24 | 91.34 on 01/05/24 | ||
High | 99.25 on 01/08/24 | 32.88 on 01/08/24 | 173.25 on 06/21/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 15,611,934 | 16,466,345 | 14,575,601 | ||
Shares Outstanding, K | 189,880 | 661,299 | 94,524 | ||
Annual Sales | 2,419,230,000 | 2,392,030,000 | 1,243,340,000 | ||
Annual Net Income | 167,650,000 | 631,910,000 | -535,980,000 | ||
Last Quarter Sales | 648,830,000 | 603,220,000 | 413,460,000 | ||
Last Quarter Net Income | 88,660,000 | 192,920,000 | 36,120,000 | ||
60-Month Beta | 0.32 | 0.97 | 0.89 | ||
Per-Share Information | |||||
Most Recent Earnings | 0.71 on 04/24/24 | 0.16 on 05/02/24 | 0.73 on 05/01/24 | ||
Latest Earnings Date | 07/29/24 | 08/01/24 | 08/07/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 60.84 | 19.26 | 1,306.25 |